Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone Acetate for Leuprolide-Induced Bleeding
NCT01776203Phase 4Terminated
- Sponsor
- Kaiser Permanente
- Start
- Jan 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of medroxyprogesterone acetate in dysfunctional uterine bleeding (DUB), sponsored by Kaiser Permanente. Started Jan 2012; status: terminated.
02
Drugs
medroxyprogesterone acetate
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on NCT01776203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01776203.